StockWatch
·

Aspira Pathlab & Diagnostics Ltd Q1 FY26 Results

ASPIRAQ1 FY26 Results
Filing
MetricValue ( Cr)vs Q4 FY25
Revenue5.259.2%
Total Income5.369.3%
Expenditure4.895.7%
PBT0.4731.0%
Net Profit0.4238.1%
OPM15.64%1.85pp
NPM7.87%3.65pp
EPS0.4137.9%
View full financials

Informational and educational content only. Not investment advice.